| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c3eac69500288b4c24f1796219481d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38d5791adbdbeaa2b91c31478ac5627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af495868c879e4a88689c2fdb579f503 |
| publicationDate |
2003-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003212792-A |
| titleOfInvention |
New angiogenesis promoter |
| abstract |
(57) [Summary] [Object] To provide a novel prophylactic / therapeutic agent having an angiogenesis promoting action. A pro-angiogenic agent comprising activated protein C as a main active ingredient derived from plasma or prepared using gene recombination technology. |
| priorityDate |
2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |